Locations:
Search IconSearch
August 28, 2017/Digestive/Case Study

Treatment of “Unresectable” Bilobar Liver Metastasis Using a 2-Stage Approach and HAI: A Case Study

Experienced team, innovative treatment

17-DDI-3877-Quintini-CQD-Hero

By Cristiano Quintini, MD

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Presentation

A 42-year-old female was referred to our institution with large right colon cancer and synchronous bilobar liver metastasis (see presenting CT scan of the liver above). A particular challenge was presented by the lesion encasing the three hepatic veins of the liver (see arrows).

Treatment

The patient received three months of perioperative chemotherapy and was scheduled (three months after the initial presentation) for a two-stage hepatectomy and a combined resection of the primary right colon tumor.

The first surgery included a right hemicolectomy with resection of all the left-sided liver lesions. The surgery was uneventful. On postoperative day 6, the patient underwent a right portal vein embolization with the intent to induce hypotrophy of the right hemi liver and the hypertrophy of the left hemi liver. This approach is used to decrease the risks of postresection liver failure.

Six weeks after the first operation, the patient underwent a right hepatectomy. Given her young age and the extent of the disease, the decision was made to place to also place a hepatic artery infusion (HAI) pump to further decrease her likelihood of recurrence. HAI locoregional treatment is an innovative approach that improves survival after liver resection for metastatic colon cancer. This treatment option is only delivered in selected centers around the world.

The remnant left liver lobe with a catheter inside the gastro-duodenal artery for HAI treatment.

The remnant left liver lobe with a catheter inside the gastro-duodenal artery for HAI treatment.

Outcome

One year after the initial presentation, the patient is free of tumor (see scan below) and receiving routine follow-up scans.

Advertisement

CT scan showing the patient free of tumor.

CT scan showing the patient free of tumor.

Advertisement

Related Articles

Dr. Regueiro in Operating Room
August 24, 2026/Digestive/Q&A

IBD LIVE Marks 15 Years of Case-Based, Multidisciplinary Education

Real-time case discussion connects IBD specialists across disciplines, institutions and countries

Empty operating room
August 20, 2026/Digestive/Surgery

Lower Air Turnover in Unoccupied ORs Shows Safety and Savings Potential

Findings show significant energy savings and no association with increased surgical site infection, mortality or ICU admission

Dr. Chung speaking with patient
August 13, 2026/Digestive/Surgery

Multidisciplinary Approach Enables Aggressive Treatment for Rare, Locally Advanced Cloacal Cancer

A complex pelvic exenteration underscores the importance of early multidisciplinary planning for locally invasive cancers

physician using model of liver
August 6, 2026/Digestive/Research

Early Return to Drinking After Alcohol-Associated Hepatitis Remains Common Despite Recovery

Findings may help guide earlier AUD intervention

Dr. de Buck with patient
July 2, 2026/Digestive/Surgery

Cleveland Clinic Among Early U.S. Adopters of Appendectomy for Ulcerative Colitis

Landmark trial data suggest appendectomy may reduce relapse and improve remission rates in select patients

Dr. Sommovilla speaking with patient
June 29, 2026/Digestive/Research

FAP: New Study Compares Postoperative Outcomes After Total Colectomy With Ileorectal Anastomosis vs. Proctocolectomy With IPAA

Implications for surgical decision-making and patient management

Dr. Prabhu
June 8, 2026/Digestive/Surgery

Ajita Prabhu, MD, Appointed New Chair of General Surgery

Dr. Prabhu discusses mentorship, collaboration and her vision for the future of the department

Patient speaking with clinician

How Cleveland Clinic’s Gastrointestinal Cancer Program Is Working to Reshape Screening, Care and Outcomes

New program looks to innovative approaches for advancing early detection and multicancer prevention

Ad